Healthcare Select Sector SPDR (XLV) 69.57 $XLV The Top

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Healthcare Select Sector SPDR (XLV) 69.57 $XLV

The Top Healthcare ETF on the Market
Brian Feroldi, The Motley Fool - Motley Fool - Mon Nov 09, 6:47AM CST
Image source: stevepb via Pixabay. Roughly 10,000 American baby boomers will turn 65 today. The same goes for tomorrow. And the next day. And every single day after that for the next 19 years. Given that the demand for healthcare increases as we...
XLV: 69.57 (-0.17)

5 Sectors You Should Under-Weight Based on Their ETFs
at The Street - Thu Nov 05, 9:05AM CST
The second half of 2015 has been extremely volatile, as the charts on these sectors show.
XLP: 47.83 (-0.42), XLY: 77.73 (-2.10), XLK: 42.37 (-0.85), XLI: 53.52 (-0.24), XLV: 69.57 (-0.17)

3 High-Momentum Health Care Stocks That Will Keep Their Mojo in 2016
at The Street - Wed Nov 04, 9:51AM CST
As the health sector continues to outpace the broader market, we pinpoint three health-related companies that should maintain their upward trajectory into next year and beyond.
ESRX: 82.99 (-1.47), MDT: 74.46 (+0.25), CERN: 56.55 (-1.15), XLV: 69.57 (-0.17)

Stocks Rally to Begin 'Pivotal' Week For Rates Outlook
at The Street - Mon Nov 02, 3:03PM CST
November extends October's stellar run in the beginning of what will be a crucial week for Federal Reserve watchers.
V: 78.11 (-0.20), CLX: 120.74 (-1.09), SHPG: 203.58 (-2.36), EL: 82.66 (-1.69), HPQ: 13.11 (-0.20), DYAX: 34.42 (+0.03), XLV: 69.57 (-0.17)

5 Best Performing Stocks of October
Swarup Gupta - Zacks Investment Research - Mon Nov 02, 1:52PM CST
Markets posted their best monthly performance in four years in October.
KO: 41.38 (-0.20), AMZN: 642.35 (-23.25), UNH: 111.41 (-1.41), HA: 35.25 (-0.54), XOM: 78.10 (-1.31), BA: 142.59 (+0.05), XL: 36.76 (-0.38), XLV: 69.57 (-0.17), IBM: 131.75 (-1.29), GILD: 102.57 (-1.66), CACI: 95.98 (-2.08), WIRE: 43.65 (+0.40), GM: 34.31 (-0.78), CVX: 88.68 (-1.18), MSFT: 52.84 (-0.48), AAPL: 112.34 (-3.38)

Stocks Extend Gains as Health Care Leads
at The Street - Mon Nov 02, 1:49PM CST
Stocks extend gains Monday afternoon as the health care sector rallies.
CLX: 120.74 (-1.09), PFE: 33.27 (-0.12), AMGN: 151.55 (+0.57), HPQ: 13.11 (-0.20), DYAX: 34.42 (+0.03), XLV: 69.57 (-0.17), JNJ: 99.88 (-0.39), V: 78.11 (-0.20), GILD: 102.57 (-1.66), S: 4.18 (+0.04), SHPG: 203.58 (-2.36), MRK: 53.03 (unch), CMG: 592.89 (-21.79), EL: 82.66 (-1.69), NVS: 86.28 (-0.58)

Stocks Higher as Dyax Deal Boosts Health Care
at The Street - Mon Nov 02, 10:30AM CST
Stocks break free of range-bound trading by late morning Monday as Shire's deal to buy Dyax boosts the health care sector.
CLX: 120.74 (-1.09), PFE: 33.27 (-0.12), AMGN: 151.55 (+0.57), HPQ: 13.11 (-0.20), DYAX: 34.42 (+0.03), XLV: 69.57 (-0.17), JNJ: 99.88 (-0.39), V: 78.11 (-0.20), GILD: 102.57 (-1.66), S: 4.18 (+0.04), CMG: 592.89 (-21.79), SHPG: 203.58 (-2.36), MRK: 53.03 (unch), EL: 82.66 (-1.69), NVS: 86.28 (-0.58)

S&P 500 ETFs Vs Ex-Sector ETFs
Zacks Equity Research - Zacks Investment Research - Tue Oct 20, 10:38AM CDT
Inside the head-to-head comparison between the S&P 500 ETF and ProShares new ex-sector ETFs.
SPXV: 43.19 (+0.29), SPXE: 41.82 (-0.63), SPXT: 42.50 (+0.29), SPY: 202.54 (-2.30), XLK: 42.37 (-0.85), SPXN: 42.88 (unch), XLF: 23.92 (-0.20), XLV: 69.57 (-0.17), XLE: 65.98 (-0.27)

Breakthrough Biotech ETF on Cancer Treatment
Zacks Equity Research - Zacks Investment Research - Mon Oct 19, 12:54PM CDT
Want exposure to an innovative biotech field? The first cancer immunotherapy ETF (CNCR) is now within your reach.
BBP: 30.44 (+0.39), BBC: 29.65 (+0.40), SBIO: 31.44 (+0.47), CNCR: 29.36 (+0.40), IBB: 323.64 (+3.53), XLV: 69.57 (-0.17)

Obamacare Lifting Demand for Services Premier Has to Offer
at The Street - Fri Oct 16, 4:20PM CDT
Premier CEO Susan DeVore says her health care company is beating the market.
PINC: 34.26 (+0.06), XLV: 69.57 (-0.17)

UnitedHealth Solid Q3 Put These ETFs in Focus
Sweta Killa - Zacks Investment Research - Fri Oct 16, 9:49AM CDT
Investors may want to look at the these ETFs as UnitedHealth continued its long streak of earnings beat but saw rough trading.
IHF: 120.89 (-0.02), MTUM: 71.05 (-1.18), IYH: 146.90 (-0.07), UNH: 111.41 (-1.41), DIA: 172.61 (-2.06), FHLC: 33.41 (unch), VHT: 128.64 (-0.11), XLV: 69.57 (-0.17)

J&J Posts Mixed Q3 Bag: ETFs in Focus
Sweta Killa - Zacks Investment Research - Wed Oct 14, 8:57AM CDT
These ETFs are in focus given that Johnson & Johnson continued its long streak of earnings beat but missed on revenues.
IHE: 155.56 (+1.55), JNJ: 99.88 (-0.39), IYH: 146.90 (-0.07), GILD: 102.57 (-1.66), ABBV: 59.86 (-0.37), VHT: 128.64 (-0.11), XLV: 69.57 (-0.17)

These 3 Sector ETFs Got Crushed Last Quarter -- Will They Bounce Back?
Dan Caplinger, The Motley Fool - Motley Fool - Sun Oct 11, 10:40AM CDT
Investors had to deal with market volatility during the summer months, as a long-awaited correction in major market benchmarks finally happened on concerns about a slowdown in the global economy. As those who invest in sector-specific exchange-traded...
XLB: 44.40 (+0.56), XLV: 69.57 (-0.17), XLE: 65.98 (-0.27)

Correction in Health Care Stocks Remains in Full Force
at The Street - Thu Oct 08, 3:00PM CDT
Have we reached the point where something will be done about it?
CI: 131.57 (+0.18), ANTM: 132.55 (-0.88), HCA: 66.45 (+1.34), XBI: 68.27 (-0.05), UNH: 111.41 (-1.41), IBB: 323.64 (+3.53), XLV: 69.57 (-0.17)

5 Sector Favorites for Q3 Earnings & Their Hot ETFs
Sweta Killa - Zacks Investment Research - Thu Oct 08, 10:10AM CDT
These sector ETFs are expected to be the winners this earnings season.
DHI: 30.67 (-0.32), JNJ: 99.88 (-0.39), LEN: 48.35 (-0.35), JPM: 65.56 (-0.44), PFE: 33.27 (-0.12), ITB: 26.81 (-0.30), CARZ: 35.85 (-0.27), WFC: 54.57 (-0.60), BRK.B: 131.96 (-0.82), XLF: 23.92 (-0.20), IYT: 144.21 (-0.89), XLV: 69.57 (-0.17)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Arclin's Bold Bet: Expanding Nomex Capacity in Spain

Updated Category News Views 5

Arclin's Strategic Move for Nomex® Expansion Looks like Arclin’s not messing around. They're throwing some serious cash down in Asturias, Spain, to ramp up production of Nomex®—a material hotter than a blacktop in July with demand surging across aerospace, electric vehicles, and defense sectors. "When we bought the Nomex® business, we committed to investing in its...

Continue Reading
Unicycive Faces Stock Plunge and Legal Woes After FDA Setback

Updated Category News Views 5

Unicycive's Rough Ride: Not Just a Bump Picture this: Your stock takes a nosedive over 39% in a day, just after a critical drug application gets slammed by the FDA—for the second time. That’s the story with Unicycive Therapeutics, Inc., ticker NASDAQ: UNC, a company that's been handing out one nail-biting moment after another to its investors. It's not just a minor...

Continue Reading
ELEGOO's M1 Ultra: Bridging Gap in 3D Scanning Tech

Updated Category News Views 0

A Leap in 3D Scanning: Say Hello to M1 Ultra ELEGOO isn't just fiddling with a toy here—this Shenzhen-based juggernaut is rolling out the M1 Ultra on October 29, 2026, and it's causing quite a stir. While the stock market doesn't see immediate tremors from every shiny new gadget, there’s something to say when a company that pulled over $300 million in sales last year...

Continue Reading
Side Bolsters Art Division with Roboto Acquisition

Updated Category News Views 7

Breaking Into China's Game Art Market The gaming industry's latest buzz centers around Side's acquisition of Roboto Entertainment, a boutique art studio known for crafting immersive game environments. This isn't just another headline grab—this move puts Side smack dab in the heart of China's burgeoning game market with a fresh Chengdu base. Expansion With Strategic...

Continue Reading
S&T Bancorp Hits Record Highs in Q3 2026

Updated Category News Views 3

Surpassing Expectations with Record Metrics Well, if it isn’t another stellar quarter for S&T Bancorp (NASDAQ:STBA). The folks over in Indiana, PA, just threw down some serious numbers. The third quarter of 2026 saw net income climbing to $38.6 million, up from $36.6 million last quarter. That's a decent hike if you ask me. But what really stole the spotlight here was...

Continue Reading
Savarese Joins RID to Drive Diagnostic Innovation

Updated Category News Views 5

A Seasoned Leader Bolsters RID's Ambitions Mario Savarese has joined Rapid Infection Diagnostics Inc.'s Strategic Advisory Board, and let me tell ya, this move's got potential. Appointing a heavyweight like Savarese as an advisor isn’t just a nod to his hefty resume. It’s about vaulting a burgeoning company into the big leagues. He's got over 20 years steering a ship...

Continue Reading
Tairex's AI System Targets Global Healthcare Gaps

Updated Category News Views 6

AI Meets Human Expertise in Clinical Decision-Making Look, in the labyrinth of healthcare, we’re seeing a revolution with AI stepping in—not to replace the doctor, but to stand alongside them like a trusty assistant. Tairex, from the halls of Tsinghua University's Institute for AI Industry Research (AIR), has thrown its hat into this ring by unveiling their...

Continue Reading
Montega Kicks Off Agilyx Sponsored Equity Research

Updated Category News Views 1

A Fresh Take on Agilyx's Market Standing Alright, folks. Agilyx ASA just got a new ticket for the analytical rodeo as Montega AG dives into sponsored equity research on the company. For those who aren't fluent in the arcane dialect of stock enthusiasts like yours truly, this means Agilyx now has another sharp set of eyes evaluating their every move, and let me tell you,...

Continue Reading
Nel ASA Welcomes Morten Holum as New CEO by 2027

Updated Category News Views 7

Nel ASA's New Leader Announced In the latest shake-up at Nel ASA (OSE: NEL), Morten Holum is getting ready to take the reins as CEO. By May 1, 2027, Holum will step into the shoes left by Håkon Volldal. And folks, this isn't your average leadership swap. Holum brings a hefty toolkit to this hydrogen powerhouse, having been part of the action across the hydrogen value...

Continue Reading
Amcor's Q3 2026 Results Loom: What's at Stake?

Updated Category News Views 3

Anticipation Builds for Amcor's Q3 2026 Financials Well, here we are again, staring down the barrel of another quarterly earnings report from Amcor plc (NYSE: AMCR). They've circled November 4th, 2026, in red on their calendars to dish out the numbers after the U.S. market's last bell rings. Investors, analysts, and the peanut gallery will be tuning in, and why not? At a...

Continue Reading

Top 5 Most Recently Viewed Articles

Ontex Group to Announce Shareholding Details Soon

Updated Category News Views 51

Significant Shareholding Notification by Ontex Group NV Ontex Group NV is committed to transparency and compliance with regulatory requirements. Recently, the company disclosed a significant shareholding notification that it received regarding Black Creek Investment Management Inc. This notification aligns with the Belgian Law concerning significant shareholdings in...

Continue Reading
TriNet Set to Announce First Quarter Results Soon

Updated Category News Views 154

TriNet's Upcoming Financial Report Announcement TriNet (NYSE: TNET), a prominent provider of human resources solutions tailored for small and medium-sized businesses (SMBs), is gearing up to reveal its financial results for the first quarter previously ended on March 31. The announcement is set to take place before the U.S. market opens on April 25. Details of the...

Continue Reading
PTC Therapeutics: Upcoming Q3 2025 Financial Results Call

Updated Category News Views 166

PTC Therapeutics Plans Third Quarter 2025 Financial Call PTC Therapeutics, Inc. (NASDAQ: PTCT) has announced that it will host a conference call to discuss its financial results for the third quarter of 2025. This upcoming event is set to take place on November 4 at 4:30 p.m. ET. It promises to provide valuable insights into the company's performance and strategic...

Continue Reading
Enhancing Maritime Safety with PntGuard™ Against Spoofing Threats

Updated Category News Views 201

Introducing PntGuard™ for Enhanced Maritime Security PntGuard™ is a revolutionary maritime-security solution designed to protect vessels from the dangers of GNSS spoofing and jamming. As the maritime sector faces growing threats from malicious disruptions of GNSS signals, PntGuard™ stands as a beacon of reliability, ensuring crews can navigate with confidence. This...

Continue Reading
Scienture Holdings Expands Market Reach with Arbli™ Agreements

Updated Category News Views 162

Scienture Holdings Enhances Healthcare Access with New Agreements Signifying a potential reach into about 20% of the U.S. institutional market, Scienture Holdings, Inc. (NASDAQ: SCNX) is paving the way for Arbli™ (losartan potassium) across a range of healthcare facilities. The U.S. losartan market, valued at $256 million annually, witnesses around 71 million...

Continue Reading